Concepedia

Warren A. Dorsch

WA

Statistics

Publications

7

Citations

424

H-Index

7

Active since

2002

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Vertex Pharmaceuticals (Canada)

University at Albany, State University of New York

Warren A. Dorsch is an author at Vertex Pharmaceuticals (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2002–2017

7

Publications

7

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 207 citations · Full text

, , +13

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases

Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock et al. · Journal of Medicinal Chemistry · 2015 · 87 citations

, , +16

Total Synthesis of (±)-<i>O</i>-Methyl PD 116740

Frank M. Hauser, Warren A. Dorsch, Dipakranjan Mal · Organic Letters · 2002 · 50 citations

A New Regiospecific Preparation of Xanthones

Frank M. Hauser, Warren A. Dorsch · Organic Letters · 2003 · 37 citations

Development of a Scalable Synthesis of an Azaindolyl-Pyrimidine Inhibitor of Influenza Virus Replication

Jianglin Liang, John E. Cochran, Warren A. Dorsch et al. · Organic Process Research & Development · 2016 · 20 citations

, , +19

1–5 of 7